Regulation of T Lymphocyte Metabolism

Journal of Immunology

Volumn 172, Issue 8, 2004, Pages 4661-4665

  Frauwirth, Kenneth A ^a   Thompson, Craig B ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR;

BIOSYNTHESIS; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; ENERGY; GLUCOSE METABOLISM; GLYCOLYSIS; HOMEOSTASIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; METABOLISM; PRIORITY JOURNAL; SECRETORY CELL; SHORT SURVEY; T LYMPHOCYTE;

EID: 1842581892     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.8.4661     Document Type: Short Survey

References (38)

1. Hume, D. A., J. L. Radik, E. Ferber, and M. J. Weidemann. 1978. Aerobic glycolysis and lymphocyte transformation. Biochem. J. 174:703.
2. Tollefsbol, T. O., and H. J. Cohen. 1985. Culture kinetics of glycolytic enzyme induction, glucose utilization, and thymidine incorporation of extended-exposure phytohemagglutinin-stimulated human lymphocytes. J. Cell Physiol. 122:98.
3. Frauwirth, K. A., J. L. Riley, M. H. Harris, R. V. Parry, J. C. Rathmell, D. R. Plas, R. L. Elstrom, C. H. June, and C. B. Thompson. 2002. The CD28 signaling pathway regulates glucose metabolism. Immunity 16:769.
4. Buttgereit, F., G. R. Burmester, and M. D. Brand. 2000. Bioenergetics of immune functions: fundamental and therapeutic aspects. Immunol. Today 21:192.
5. Rathmell, J. C., M. G. Vander Heiden, M. H. Harris, K. A. Frauwirth, and C. B. Thompson. 2000. In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol. Cell. 6:683.
6. Rathmell, J. C., E. A. Farkash, W. Gao, and C. B. Thompson. 2001. IL-7 enhances the survival and maintains the size of naive T cells. J. Immunol 167:6869.
7. Roos, D., and J. A. Loos. 1973. Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. II. Relative importance of glycolysis and oxidative phosphorylation on phytohaemagglutinin stimulation. Exp. Cell Res. 77:127.
8. Sagone, A. L., Jr., A. F. LoBuglio, and S. P. Balcerzak. 1974. Alterations in hexose monophosphate shunt during lymphoblastic transformation. Cell. Immunol. 14:443.
9. Culvenor, J. G., and M. J. Weidemann. 1976. Phytohaemagglutinin stimulation of rat thymus lymphocytes glycolysis. Biochim. Biophys. Acta 437:354.
10. Krauss, S., M. D. Brand, and F. Buttgereit. 2001. Signaling takes a breath-new quantitative perspectives on bioenergetics and signal transduction. Immunity 15:497.
11. Warburg, O. 1956. On respiratory impairment in cancer cells. Science 124:269.
12. Cong, L. N., H. Chen, Y. Li, L. Zhou, M. A. McGibbon, S. I. Taylor, and M. J. Quon. 1997. Physiological rate of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Mol. Endocrinol. 11:1881.
13. Wang, Q., R. Somwar, P. J. Bilan, Z. Liu, J. Jin, J. R. Woodgett, and A. Klip. 1999. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell. Biol. 19:4008.
14. Summers, S. A., V. P. Yin, E. L. Whiteman, L. A. Garza, H. Cho, R. L. Tuttle, and M. J. Birnbaum. 1999. Signaling pathways mediating insulin-stimulated glucose transport. Ann. NY Acad. Sci. 892:169.
15. Parry, R. V., K. Reif, G. Smith, D. M. Sansom, B. A. Hemmings, and S. G. Ward. 1997. Ligation of the T cell co-stimulatory receptor CD28 activates the serine-threonine protein kinase protein kinase B. Eur. J. Immunol. 27:2495.
16. Riley, J. L., M. Mao, S. Kobayashi, M. Biery, J. Burchard, G. Cavet, B. P. Gregson, C. H. June, and P. S. Linsley. 2002. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc. Natl. Acad. Sci. USA 99:11790.
17. Kohn, A. D., S. A. Summers, M. J. Birnbaum, and R. A. Roth. 1996. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol. Chem. 271:31372.
18. Ueki, K., R. Yamamoto-Honda, Y. Kaburagi, T. Yamauchi, K. Tobe, B. M. Burgering, P. J. Coffer, I. Komuro, Y. Akanuma, Y. Yazaki, and T. Kadowaki. 1998. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J. Biol. Chem. 273:5315.
19. Rathmell, J. C., R. L. Elstrom, R. M. Cinalli, and C. B. Thompson. 2003. Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma. Eur. J. Immunol. 33:2223.
20. Barthel, A., S. T. Okino, J. Liao, K. Nakatani, J. Li, J. P. Whitlock, Jr., and R. A. Roth. 1999. Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1. J. Biol. Chem. 274:20281.
21. Rathmell, J. C., C. J. Fox, D. R. Plas, P. S. Hammerman, R. M. Cinalli, and C. B. Thompson. 2003. Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol. Cell. Biol. 23:7315.
22. Gottlob, K., N. Majewski, S. Kennedy, E. Kandel, R. B. Robey, and N. Hay. 2001. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 15:1406.
23. Van Schaftingen, E., L. Hue, and H. G. Hers. 1980. Fructose 2,6-bisphosphate, the probably structure of the glucose- and glucagon-sensitive stimulator of phosphofructokinase. Biochem. J. 192:897.
24. Van Schaftingen, E., and H. G. Hers. 1981. Phosphofructokinase 2: the enzyme that forms fructose 2,6-bisphosphate from fructose 6-phosphate and ATP. Biochem. Biophys. Res. Commun. 101:1078.
25. Deprez, J., D. Vertommen, D. R. Alessi, L. Hue, and M. H. Rider. 1997. Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades. J. Biol. Chem. 272:17269.
26. Chuang, E., T. S. Fisher, R. W. Morgan, M. D. Robbins, J. M. Duerr, M. G. Vander Heiden, J. P. Gardner, J. E. Hambor, M. J. Neveu, and C. B. Thompson. 2000. The CD28 and CTLA-4 receptors associate with the serine/ threonine phosphatase PP2A. Immunity 13:313.
27. Millward, T. A., S. Zolnierowicz, and B. A. Hemmings. 1999. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 24:186.
28. Chen, W. S., P. Z. Xu, K. Gotrlob, M. L. Chen, K. Sokol, T. Shiyanova, I. Roninson, W. Weng, R. Suzuki, K. Tobe, et al. 2001. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15:2203.
29. Cho, H., J. Mu, J. K. Kim, J. L. Thorvaldsen, Q. Chu, E. B. Crenshaw III, K. H. Kaestner, M. S. Bartolomei, G. I. Shulman, and M. J. Birnbaum. 2001. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292:1728.
30. Cho, H., J. L. Thorvaldsen, Q. Chu, F. Feng, and M. J. Birnbaum. 2001. Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276:38349.
31. Peng, X. D., P. Z. Xu, M. L. Chen, A. Hahn-Windgassen, J. Skeen, J. Jacobs, D. Sundararajan, W. S. Chen, S. E. Crawford, K. G. Coleman, and N. Hay. 2003. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 17:1352.
32. Schmelzle, T., and M. N. Hall. 2000. TOR, a central controller of cell growth. Cell 103:253.
33. Gerber, D. A., C. A. Bonham, and A. W. Thomson. 1998. Immunosuppressive agents: recent developments in molecular action and clinical application. Transplant. Proc. 30:1573.
34. Edinger, A. L., and C. B. Thompson. 2002. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol. Biol. Cell 13:2276.
35. Gortesdiener, K. M., Karpinski, B. A., Lindsten, T., Strominger, J. L., Jones, N. H., Thompson, C. B., and Leiden, J. M. 1988. Isolation and structural characterization of the human 4F2 heavy-chain gene, an inducible gene involved in T-lymphocyte activation. Mol. Cell. Biol. 8:3809.
36. Plas, D. R., and Thompson, C. B. 2003. Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. J. Biol. Chem. 278:12361.
37. Rutter, G. A., G. Da Silva Xavier, and I. Leclerc. 2003. Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem. J. 375:1.
38. Kovacic, S., C. L. Solrys, A. J. Barr, I. Shiojima, K. Walsh, and J. R. Dyck. 2003. Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J. Biol. Chem. 278:39422.